CyberOncology Network Project
Not Applicable
Recruiting
- Conditions
- malignant tumor
- Registration Number
- JPRN-UMIN000044646
- Lead Sponsor
- Kyoto University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 5000
Inclusion Criteria
Not provided
Exclusion Criteria
Cases that the researcher deems inappropriate for participating in this study.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Own data 1) Statistical data (A) Cancer type (OncoTree, ICD-O-3): Number of patients (new / total) / diagnosis date (B) Chemotherapy (number / content): Patient (new / total), drug, regimen (C) Basic patient information: age, gender, PS, cStage (TNM), race (D) Treatment method (number / content): Chemotherapy / surgery / radiation 2) Treatment results (A) Progression-free survival (postoperative chemotherapy is recurrence-free survival): Cancer type, line, regimen (B) Successful treatment period: Cancer type, line, regimen (C) Overall survival: cancer type, line, regimen (D) Response rate: Cancer type, line, regimen 3) Adverse events (A) Cancer type / line / regimen (B) SAE report
- Secondary Outcome Measures
Name Time Method Multicenter integrated data 1) Statistical data (A) Cancer type (OncoTree, ICD-O-3): Number of patients (new / total) / diagnosis date (B) Chemotherapy (number / content): Patient (new / total), drug, regimen (C) Basic patient information: age, gender, PS, cStage (TNM), race (D) Treatment method (number / content): Chemotherapy / surgery / radiation 2) Treatment results (A) Progression-free survival (postoperative chemotherapy is recurrence-free survival): Cancer type, line, regimen (B) Successful treatment period: Cancer type, line, regimen (C) Overall survival: cancer type, line, regimen (D) Response rate: Cancer type, line, regimen 3) Adverse events (A) Cancer type / line / regimen (B) SAE report